Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
1546 | 6833 | 49.6 | 91% |
Classes in level above (level 3) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
117 | 66828 | GAP JUNCTION//BRAIN DERIVED NEUROTROPHIC FACTOR//CONNEXIN |
Classes in level below (level 1) |
ID, lev. below | Publications | Label for level below |
---|---|---|
3459 | 1904 | EPHRIN//EPH//EPHA2 |
4432 | 1713 | NETRIN//NETRIN 1//ROBO |
5129 | 1600 | SEMAPHORIN//PLEXIN//NEUROPILIN |
7409 | 1291 | GROWTH CONE//GROWTH CONES//NEURONAL POLARITY |
22430 | 325 | COLLAPSIN RESPONSE MEDIATOR PROTEIN//CRMP2//CRMP 2 |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | SEMAPHORIN | Author keyword | 462 | 79% | 4% | 299 |
2 | EPHRIN | Author keyword | 307 | 70% | 4% | 252 |
3 | PLEXIN | Author keyword | 266 | 88% | 2% | 123 |
4 | AXON GUIDANCE | Author keyword | 264 | 41% | 7% | 504 |
5 | EPH | Author keyword | 228 | 78% | 2% | 149 |
6 | NEUROPILIN | Author keyword | 173 | 69% | 2% | 149 |
7 | NETRIN 1 | Author keyword | 154 | 74% | 2% | 113 |
8 | NETRIN | Author keyword | 150 | 73% | 2% | 116 |
9 | EPHA2 | Author keyword | 129 | 75% | 1% | 94 |
10 | ROBO | Author keyword | 127 | 75% | 1% | 91 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | SEMAPHORIN | 462 | 79% | 4% | 299 | Search SEMAPHORIN | Search SEMAPHORIN |
2 | EPHRIN | 307 | 70% | 4% | 252 | Search EPHRIN | Search EPHRIN |
3 | PLEXIN | 266 | 88% | 2% | 123 | Search PLEXIN | Search PLEXIN |
4 | AXON GUIDANCE | 264 | 41% | 7% | 504 | Search AXON+GUIDANCE | Search AXON+GUIDANCE |
5 | EPH | 228 | 78% | 2% | 149 | Search EPH | Search EPH |
6 | NEUROPILIN | 173 | 69% | 2% | 149 | Search NEUROPILIN | Search NEUROPILIN |
7 | NETRIN 1 | 154 | 74% | 2% | 113 | Search NETRIN+1 | Search NETRIN+1 |
8 | NETRIN | 150 | 73% | 2% | 116 | Search NETRIN | Search NETRIN |
9 | EPHA2 | 129 | 75% | 1% | 94 | Search EPHA2 | Search EPHA2 |
10 | ROBO | 127 | 75% | 1% | 91 | Search ROBO | Search ROBO |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | AXON GUIDANCE | 416 | 39% | 12% | 837 |
2 | COMMISSURAL AXONS | 369 | 71% | 4% | 299 |
3 | TRANSMEMBRANE LIGANDS | 346 | 87% | 2% | 167 |
4 | EPHRINS | 219 | 79% | 2% | 141 |
5 | GROWTH CONE COLLAPSE | 215 | 59% | 4% | 244 |
6 | SEMAPHORIN III | 205 | 65% | 3% | 195 |
7 | PERIPHERAL NERVE PROJECTION | 202 | 83% | 2% | 115 |
8 | EPH RECEPTORS | 159 | 48% | 4% | 246 |
9 | GROWTH CONE GUIDANCE | 138 | 37% | 4% | 298 |
10 | SECRETED SEMAPHORINS | 131 | 84% | 1% | 72 |
Journals |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NEURAL DEVELOPMENT | 3 | 10% | 0% | 29 |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Therapeutic targeting of EPH receptors and their ligands | 2014 | 31 | 297 | 84% |
Eph-ephrin bidirectional signaling in physiology and disease | 2008 | 474 | 84 | 83% |
Eph receptors and ephrins in cancer: bidirectional signalling and beyond | 2010 | 307 | 223 | 77% |
EPH receptor signalling casts a wide net on cell behaviour | 2005 | 537 | 129 | 86% |
VEGF targets the tumour cell | 2013 | 77 | 192 | 41% |
Bidirectional modulation of synaptic functions by Eph/ephrin signaling | 2009 | 201 | 46 | 80% |
Molecular mechanisms of axon guidance | 2002 | 793 | 109 | 85% |
Molecular dynamics in drug design | 2015 | 3 | 13 | 38% |
Common mechanisms of nerve and blood vessel wiring | 2005 | 466 | 98 | 74% |
The role of semaphorins and their receptors in vascular development and cancer | 2013 | 27 | 98 | 80% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOL PHARMACOL NEUROBIOL | 38 | 53% | 0.7% | 51 |
2 | OPTOSIS CANC DEV EQUIPE ELLISEE LA LIG | 21 | 85% | 0.2% | 11 |
3 | OPTOSIS CANC DEV | 13 | 58% | 0.2% | 15 |
4 | MICROSCOPY CYTOMETRY | 13 | 80% | 0.1% | 8 |
5 | GRP DEV NEUROBIOLCHIKUSA KU | 13 | 71% | 0.1% | 10 |
6 | NEURONAL GROWTH MECH | 12 | 52% | 0.2% | 16 |
7 | KENT WALDREP BASIC NERVE GROWTH REGENER | 11 | 54% | 0.2% | 14 |
8 | PAUL CAROLE STARK NEUROSCI | 9 | 44% | 0.2% | 16 |
9 | EXPT NEUROTHER EUT | 8 | 60% | 0.1% | 9 |
10 | EQUIPE ELLISEE LA LIGUE | 7 | 46% | 0.2% | 11 |
Related classes at same level (level 2) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000017905 | TENASCIN C//TENASCIN//POLYSIALIC ACID |
2 | 0.0000017881 | SEROFENDIC ACID//COSALANE//AURINTRICARBOXYLIC ACID |
3 | 0.0000014295 | REELIN//DAB1//VLDLR |
4 | 0.0000011424 | SPINAL CORD INJURIES//OLFACTORY ENSHEATHING CELLS//NOGO A |
5 | 0.0000010311 | AGR2//ALCAM//GICERIN |
6 | 0.0000009306 | E CADHERIN//CADHERIN//CATENINS |
7 | 0.0000009165 | LYMPHANGIOGENESIS//ANGIOGENESIS//ENDOSTATIN |
8 | 0.0000008855 | TRANSHYDROGENASE//WLDS//NAD KINASE |
9 | 0.0000008731 | WISKOTT ALDRICH SYNDROME//GELSOLIN//COFILIN |
10 | 0.0000008504 | 2 5 HEXANEDIONE//NEUROFILAMENT//NEUROFILAMENTS |